McKesson Corporation
MCKHealthcareNASDAQMedical Distribution
Scan Results
Daily timeframeHeadquartered within the healthcare sector, McKesson Corporation focuses on Medical Distribution services and products. McKesson Corporation provides healthcare services in the United States and internationally. At a $103.66B market cap, McKesson Corporation ranks as a large-cap company within healthcare. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Market Cap
$103.66B
Beta
0.31
P/E (TTM)
23.82
P/E (Fwd)
17.62
EPS (TTM)
$37.32
EPS (Fwd)
$50.47
ROE
—
ROA
4.7%
Cash
$5.16B
Total Debt
$11.80B
Free CF
$6.80B
52W Change
28.6%
Annual Financials
Cash vs Debt
Where MCK stands vs its 150-day and 200-day moving averages
As of the August 31, 2026 close, MCK finished 5.80% above its 150-day moving average ($844.45) and 6.26% above its 200-day moving average ($840.74). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MCK overbought or oversold?
At the August 31, 2026 close, MCK's RSI(14) was 53.2, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, MCK has $5.16B in cash with $11.80B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $6.80B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROA of 4.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $276.71B (2023) to $403.43B (2026), reflecting a 46% increase over the period.
The relatively low beta of 0.31 suggests MCK is a less volatile holding compared to the broader index. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence McKesson Corporation's trajectory.